iPhone | iPad
Android
Huawei
The strike comes after the company's biggest union in South Korea held a four-day strike in August demanding higher wages and bonuses
KT APPDOWNLOAD
Ten Covid-19 vaccines seen by mid-year: Global pharma group
Geneva - Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, head of global pharma group said.
Ten Covid-19 vaccines could be available by the middle of next year if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said on Friday.
Vaccines by Pfizer and BioNtech, as well as Moderna and AstraZeneca have shown promising results in large clinical trials, but there is no question of “cutting corners”, said Thomas Cueni, director-general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
“So far 3 we have 3 out of 3 were hits. I would expect that we will see something similar with Johnson & Johnson, I would expect that we would see similar positive results with Novavax, and many others, Sanofi Pasteur, GSK are in there, Merck,” he said.
‘Big Pharma’ and biotech firms have invested heavily in research and development and in boosting manufacturing during the pandemic to be able to roll out vaccine doses, Cueni told a Geneva news briefing.
It would be a mistake to lift patent protection to allow compulsory licensing and try to make vaccines requiring such complex quality assurance without expert staff and quality control procedures, he said.
“We will hopefully by the next summer have probably 10 vaccines which have proven their value. But all of them really need to be submitted by rigorous scientific scrutiny by the regulators.”
At the World Trade Organization (WTO), India and South Africa have proposed allowing a temporary waiver to allow compulsory licensing for patented products during the pandemic. The United States, European Union and Switzerland and others have rejected it, trade officials say.
Cueni, asked about the proposal, said: “For me this questioning of IP is really primarily politics, but it’s politics which is not helpful because it would send very negative signals in terms of disrespect to the system which allowed the world to react so fast and so responsibly.”
Vaccine manufacturing plants often need 50 quality assurance staff making hundreds of checks during production, he said, emphasising that the companies would not exploit the pandemic.
Cueni said that IFPMA archives showed there had never been a compulsory license granted for a vaccine and pointed to the difficult technology and know-how. Nearly every member company had committed to “not-for-profit” or socially responsible pricing during the pandemic, he added.
More news from
Mpox's resurgence with a new strain dubbed Clade 1b, prompted the World Health Organization to declare its highest international alert level
Kayal’s work has been celebrated for its use of rich textures, refined colour palettes, and meticulous attention to detail
The Court had launched the 'express civil marriage' service, through which couples can have their marriage ceremony on the same day of application
Observant residents using Max Metro Station will be able to spot the change on their commute
More than 30,000 Russians have registered for temporary residence in Serbia since February 2022
From helping businesses set up on the mainland, in free zones, or offshore, Trinity Group ensures a seamless process by handling the legal and regulatory requirements
The security council also advised users to circulate this information with various entities and partners